Smallwood et al. demonstrated that autologous patient CD4+ T cells internalize chronic lymphocytic leukemia (CLL)-derived small EVs containing miR-363 that targets the immunomodulatory receptor CD69, which leads to inhibit the migration of effector T cells [112,113,114]. Here, CD69 is linked to B-cell chronic lymphocytic leukemia.